Literature DB >> 10216744

[Prevalence of chronic bronchitis, asthma and airflow limitation in an urban-industrial area of Catalonia].

A Jaén1, A Ferrer, I Ormaza, M Rué, C Domingo, A Marín.   

Abstract

OBJECTIVES: To determine the prevalence of chronic bronchitis, asthma and airflow limitation in the general population of the urban-industrial area in and around the town of Sabadell (Catalonia, Spain), and to assess its degree of association with smoking and exposure to secondhand smoke.
METHODS: Transversal study of 642 men and women between 20 and 70 years of age listed on census rolls. The standardized questionnaire of the American Thoracic Society was used to interview 576 subjects (90%). Tests of forced spirometry with bronchodilation were administered to 497 individuals (77%).
RESULTS: The prevalence of chronic bronchitis was 11.6% (21% of men and 2.7% of women). Asthma had been diagnosed by a subject's doctor in 3.3% of the sample (2.1% of men and 4.4% of women). The prevalence of several asthma-related symptoms was higher. Dyspnea with wheezing was reported by 10.6% of the population (11.4% of men and 9.8% of women); wheezing within the past year was reported by 38.2% (45.4% of men and 31.4% of women). The prevalence of airflow limitation (defined as FEV1 < 80% with an FEV1/FVC index < 70%) in the population sample was 7.2% (10.4% of men and 4.1% of women); in men aged 60 to 70 years, however, the prevalence was 30.8%. Exposure to secondhand smoke was related to the presence of chronic coughing (OR = 4.6) and wheezing (OR = 1.8), but not to significant spirometric changes.
CONCLUSIONS: The prevalence of respiratory symptoms and airflow limitation is high in our area, particularly among men and older patients (60 to 70 years old). Like active smokers and ex-smokers, subjects who have been exposed to secondhand smoke are at greater risk of developing respiratory symptoms.

Entities:  

Mesh:

Year:  1999        PMID: 10216744     DOI: 10.1016/s0300-2896(15)30290-8

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

Review 2.  Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.

Authors:  Kokuvi Atsou; Christos Chouaid; Gilles Hejblum
Journal:  BMC Med       Date:  2011-01-18       Impact factor: 8.775

3.  Economic valuation and determinants of informal care to disabled people with Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Luz María Peña-Longobardo; Juan Oliva-Moreno; Álvaro Hidalgo-Vega; Marc Miravitlles
Journal:  BMC Health Serv Res       Date:  2015-03-15       Impact factor: 2.655

4.  Design and analysis of health products and services: An example at a specialized COPD unit.

Authors:  Christian Domingo; Vicente Ortún Rubio
Journal:  Open Respir Med J       Date:  2008-02-20

5.  Gender and respiratory findings in workers occupationally exposed to organic aerosols: a meta analysis of 12 cross-sectional studies.

Authors:  E Neil Schachter; Eugenija Zuskin; Erin L Moshier; James Godbold; Jadranka Mustajbegovic; Jasna Pucarin-Cvetkovic; Angelo Chiarelli
Journal:  Environ Health       Date:  2009-01-12       Impact factor: 5.984

6.  Occupation, smoking, and chronic obstructive respiratory disorders: a cross sectional study in an industrial area of Catalonia, Spain.

Authors:  Angeles Jaén; Jan Paul Zock; Manolis Kogevinas; Antonio Ferrer; Albert Marín
Journal:  Environ Health       Date:  2006-02-14       Impact factor: 5.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.